Yokukansan, a Traditional Japanese Medicine, Enhances the Glutamate Transporter GLT‐1 Function in Cultured Rat Cortical Astrocytes
Authors:
Open Access
- 1 January 2018
- journal article
- research article
- Published by Wiley in Evidence-Based Complementary and Alternative Medicine
- Vol. 2018 (1) , 6804017
Abstract
Astrocytes carry two glutamate transporters—GLAST and GLT‐1—the latter of which is responsible for >90% of glutamate uptake activity in the brain; however, under culture conditions, the GLT‐1 expression in astrocytes is exceedingly low, as is the glutamate uptake activity mediated by GLT‐1. This study aimed to elucidate the effects of yokukansan (YKS) in relation to the GLT‐1‐mediated regulation of extracellular glutamate concentrations. Thus, we treated cultured astrocytes with tumor necrosis factor‐α (TNF‐α) and dibutyryl‐cAMP (dBcAMP) (hereinafter, referred to as “TA”) to increase GLT‐1 expression and then functionally examined how YKS would affect glutamate uptake ability derived from GLT‐1. Contrary to expectations, although the TA treatments did not affect the uptake activity, YKS significantly augmented it. Conversely, GLAST‐derived glutamate uptake was significantly reduced by TA treatments but was unaffected by YKS. Subsequently, we analyzed the GLT‐1 protein and mRNA levels and found that TA treatments had significantly increased them, which were then further augmented by YKS. These findings suggest that YKS enhances GLT‐1‐derived glutamate transport functions in TA‐treated cultured astrocytes and that this process entails increased GLT‐1 protein and mRNA levels. This type of mechanism may contribute to the YKS‐mediated regulation of extracellular glutamate concentrations.Keywords
This publication has 43 references indexed in Scilit:
- Yokukansan in the treatment of behavioral and psychological symptoms of dementia: a systematic review and meta‐analysis of randomized controlled trialsHuman Psychopharmacology: Clinical and Experimental, 2013
- Treatment of behavioral and psychological symptoms of Alzheimer-type dementia with Yokukansan in clinical practiceProgress in Neuro-Psychopharmacology and Biological Psychiatry, 2010
- Effect of yokukansan on the behavioral and psychological symptoms of dementia in elderly patients with Alzheimer's diseaseProgress in Neuro-Psychopharmacology and Biological Psychiatry, 2009
- Downregulation of glutamate transporters is associated with elevation in extracellular glutamate concentration following rat microsphere embolismNeuroscience Letters, 2008
- Effects of the Traditional Chinese Herbal Medicine Yi-Gan San for Cholinesterase Inhibitor-Resistant Visual Hallucinations and Neuropsychiatric Symptoms in Patients With Dementia With Lewy BodiesThe Journal of Clinical Psychiatry, 2005
- Impaired glutamate transport and glutamate-glutamine cycling: downstream effects of the Huntington mutationBrain, 2002
- In Vivo Microdialysis in an Animal Model of Neurological Disease: Thiamine Deficiency (Wernicke) EncephalopathyMethods, 2001
- β‐Amyloid neurotoxicity is mediated by a glutamate‐triggered excitotoxic cascade in rat nucleus basalisEuropean Journal of Neuroscience, 2000
- Micromolar l-glutamate induces extensive apoptosis in an apoptotic-necrotic continuum of insult-dependent, excitotoxic injury in cultured cortical neuronesNeuropharmacology, 1998
- Glutamate neurotoxicity and diseases of the nervous systemNeuron, 1988